Sparse holographic imaging for an integrated augmented reality near-eye display
Applied Optics · 10.03.2023 · 62 (8) · 1928
DOI: 10.1364/ao.478849 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Optics, online erschienen am 02.03.2023. Verfasst von Christophe Martinez und 4 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Diffraction is the main physical effect involved in the imaging process of holographic displays. In the application of near-eye displays, it generates physical limits that constrain the field of view of the devices. In this contribution, we evaluate experimentally an alternative approach for a holographic display based mainly on refraction. This unconventional imaging process, based on sparse aperture imaging, could lead to integrated near-eye displays through retinal projection, with a larger field of view. We introduce for this evaluation an in-house holographic printer that allows the recording of holographic pixel distributions at a microscopic scale. We show how these microholograms can encode angular information that overcomes the diffraction limit and could alleviate the space bandwidth constraint usually associated with conventional display design.
Zitieren
APA
Martinez, C., Colard, M., Legentil, P., Millard, K., & Rainouard, F. (2023). Sparse holographic imaging for an integrated augmented reality near-eye display. Applied Optics, 62(8), 1928. https://doi.org/10.1364/ao.478849
Vancouver
Martinez C, Colard M, Legentil P, Millard K, Rainouard F. Sparse holographic imaging for an integrated augmented reality near-eye display. Applied Optics. 2023;62(8):1928. doi:10.1364/ao.478849
BibTeX
@article{Martinez2023,
author = {Martinez, Christophe and Colard, Matthias and Legentil, Paul and Millard, Kyllian and Rainouard, Fabian},
title = {Sparse holographic imaging for an integrated augmented reality near-eye display},
journal = {Applied Optics},
year = {2023},
volume = {62},
number = {8},
pages = {1928},
doi = {10.1364/ao.478849}
}
EUVIMED